See more : Sensei Biotherapeutics, Inc. (SNSE) Income Statement Analysis – Financial Results
Complete financial analysis of Omega Healthcare Investors, Inc. (OHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omega Healthcare Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- AKG Exim Limited (AKG.NS) Income Statement Analysis – Financial Results
- Beijing Kingsoft Office Software, Inc. (688111.SS) Income Statement Analysis – Financial Results
- Foods & Inns Ltd (FOODSIN.NS) Income Statement Analysis – Financial Results
- 1847 Holdings LLC (EFSH) Income Statement Analysis – Financial Results
- Tarsin Mobile, Inc. (TMIX) Income Statement Analysis – Financial Results
Omega Healthcare Investors, Inc. (OHI)
About Omega Healthcare Investors, Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 949.74M | 878.24M | 1.06B | 892.38M | 928.83M | 881.68M | 908.39M | 900.83M | 743.62M | 504.79M | 418.71M | 350.46M | 292.20M | 258.32M | 197.44M | 193.76M | 159.56M | 135.69M | 105.81M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Cost of Revenue | 106.97M | 16.97M | 13.72M | 13.76M | 16.14M | 29.84M | 99.07M | 58.73M | 17.68M | 3.66M | 415.00K | 272.00K | 653.00K | 8.00M | 159.00K | 5.58M | 1.42M | 0.00 | 5.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 842.77M | 861.28M | 1.05B | 878.62M | 912.69M | 851.84M | 809.32M | 842.10M | 725.94M | 501.13M | 418.30M | 350.19M | 291.55M | 250.32M | 197.28M | 188.18M | 158.14M | 135.69M | 100.36M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Gross Profit Ratio | 88.74% | 98.07% | 98.71% | 98.46% | 98.26% | 96.62% | 89.09% | 93.48% | 97.62% | 99.27% | 99.90% | 99.92% | 99.78% | 96.90% | 99.92% | 97.12% | 99.11% | 100.00% | 94.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.49 | 0.39 | 0.18 | 0.37 | 0.34 | 0.12 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 15.05M | 11.74M | 11.70M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00M | 20.63M | -2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 23.05M | 32.37M | 9.60M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Other Expenses | 0.00 | 401.07M | 419.75M | 367.92M | 301.68M | 287.97M | 10.41M | 286.49M | 276.10M | 129.93M | 131.03M | 113.89M | 106.78M | 84.62M | 47.46M | 71.74M | -398.00K | 32.91M | 25.31M | 24.14M | 0.00 | 0.00 | 229.33M | 296.50M | 24.21M | 21.54M | 16.91M | 13.69M | -16.60M | -9.40M | -4.60M | -1.20M |
| Operating Expenses | 81.50M | 469.00M | 482.92M | 426.36M | 358.34M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.21M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Cost & Expenses | 188.47M | 485.97M | 496.64M | 440.13M | 374.49M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.86M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Interest Income | 0.00 | 123.92M | 234.60M | 223.39M | 856.00K | 313.00K | 267.00K | 173.00K | 285.00K | 44.00K | 41.00K | 29.00K | 40.00K | 105.00K | 21.00K | 240.00K | 257.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 235.53M | 233.24M | 234.60M | 224.35M | 208.72M | 201.42M | 220.24M | 175.56M | 183.21M | 126.87M | 92.05M | 106.10M | 86.90M | 90.60M | 39.08M | 37.75M | 44.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 319.68M | 485.97M | 496.64M | 648.89M | 374.49M | 351.48M | 349.85M | 322.77M | 210.70M | 123.26M | 128.65M | 112.98M | 100.34M | 84.62M | 44.69M | 39.89M | 36.06M | 32.26M | 27.40M | 23.40M | 20.99M | 21.27M | 22.07M | 23.27M | 24.21M | 21.54M | 16.91M | 13.69M | 13.00M | 6.70M | 3.00M | 800.00K |
| EBITDA | 810.84M | 722.69M | 906.89M | 782.18M | 856.74M | 811.49M | 846.12M | 845.12M | 697.18M | 468.57M | 394.33M | 327.95M | 238.13M | 144.67M | 121.66M | 110.47M | 147.74M | 121.17M | 101.35M | 110.38M | 79.80M | 265.63M | 491.37M | -13.86M | 116.26M | 103.37M | 86.18M | 69.12M | 87.40M | 51.20M | 26.60M | 7.40M |
| EBITDA Ratio | 85.38% | 82.29% | 85.33% | 87.65% | 92.25% | 92.07% | 94.32% | 93.83% | 93.79% | 94.34% | 94.34% | 93.92% | 99.78% | 91.74% | 82.21% | 80.76% | 91.93% | 82.09% | 91.95% | 117.95% | 92.50% | 19.70% | 15.78% | -5.03% | 95.00% | 95.07% | 94.90% | 94.52% | 142.35% | 135.45% | 127.88% | 125.42% |
| Operating Income | 761.27M | 390.28M | 564.88M | 452.26M | 551.75M | 497.59M | 261.26M | 509.75M | 411.27M | 345.31M | 265.68M | 214.97M | 137.80M | 148.94M | 115.89M | 104.74M | 111.03M | 89.04M | 66.46M | 60.10M | 46.06M | 10.19M | 17.22M | -17.15M | 92.04M | 81.83M | 69.27M | 55.43M | 74.40M | 44.50M | 23.60M | 6.60M |
| Operating Income Ratio | 80.16% | 44.44% | 53.15% | 50.68% | 59.40% | 56.44% | 28.76% | 56.59% | 55.31% | 68.41% | 63.45% | 61.34% | 47.16% | 57.66% | 58.69% | 54.05% | 69.58% | 65.62% | 62.81% | 66.44% | 53.40% | 7.43% | 6.69% | -6.22% | 75.21% | 75.26% | 76.28% | 75.79% | 121.17% | 117.72% | 113.46% | 111.86% |
| Total Other Income/Expenses | -505.64M | -318.76M | -525.18M | -585.36M | -207.90M | -201.08M | -209.25M | -175.62M | -176.74M | -123.96M | -93.16M | -94.27M | -85.19M | -90.50M | -33.77M | -27.12M | -43.44M | -30.66M | -26.72M | -43.36M | -6.04M | 3.49M | -677.00K | 9.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 255.63M | 436.14M | 416.08M | 162.33M | 343.84M | 296.51M | 105.92M | 384.33M | 234.53M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 77.62M | 67.59M | 58.39M | 36.69M | 16.74M | 40.02M | 13.68M | 16.55M | -7.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 26.92% | 49.66% | 39.15% | 18.19% | 37.02% | 33.63% | 11.66% | 42.66% | 31.54% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.06% | 42.36% | 43.03% | 34.67% | 18.51% | 46.39% | 9.98% | 6.42% | -2.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 6.26M | 4.56M | 3.84M | 4.93M | 2.84M | 3.01M | 3.25M | 1.41M | 1.21M | 126.87M | 92.05M | 106.10M | 112.74M | -4.00K | 753.00K | -72.00K | -7.00K | 2.35M | 28.18M | 43.10M | 29.74M | 23.89M | 34.56M | 22.42M | 72.37M | 5.62M | 24.42M | 20.84M | 51.40M | 26.70M | 12.00M | 2.20M |
| Net Income | 242.18M | 426.93M | 416.74M | 159.33M | 341.12M | 281.58M | 100.42M | 366.42M | 224.52M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 78.14M | 69.37M | 55.70M | 36.69M | 16.74M | 23.03M | -14.65M | -16.66M | -49.56M | 19.67M | 76.21M | 44.85M | 34.59M | 23.00M | 17.80M | 11.60M | 4.40M |
| Net Income Ratio | 25.50% | 48.61% | 39.21% | 17.85% | 36.73% | 31.94% | 11.05% | 40.68% | 30.19% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.33% | 43.48% | 41.05% | 34.67% | 18.51% | 26.70% | -10.68% | -6.47% | -17.97% | 16.07% | 70.08% | 49.38% | 47.30% | 37.46% | 47.09% | 55.77% | 74.58% |
| EPS | 1.04 | 1.81 | 1.76 | 0.70 | 1.60 | 1.41 | 0.51 | 1.91 | 1.30 | 1.75 | 1.47 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| EPS Diluted | 1.00 | 1.75 | 1.71 | 0.68 | 1.54 | 1.34 | 0.51 | 1.90 | 1.29 | 1.74 | 1.46 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| Weighted Avg Shares Out | 240.49M | 236.26M | 236.93M | 227.74M | 213.40M | 200.28M | 197.74M | 191.78M | 172.24M | 126.55M | 117.26M | 107.59M | 102.12M | 94.06M | 83.56M | 75.13M | 65.86M | 58.65M | 51.74M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
| Weighted Avg Shares Out (Dil) | 250.45M | 244.29M | 244.34M | 235.10M | 222.13M | 209.71M | 206.79M | 201.64M | 180.51M | 127.29M | 118.10M | 108.01M | 102.18M | 94.24M | 83.65M | 75.21M | 65.89M | 58.75M | 52.06M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Omega Healthcare: Better Options In The Healthcare Space For Dividend Investors
Omega Health Investors has seen tenant issues and a high payout ratio above 100% during its latest quarter, putting its dividend at risk. OHI reported strong earnings in Q4 2023 beating on both revenue & FFO, but its portfolio occupancy...
Investors Keep Buying These Sizzling 4 S&P Mid-Cap Dividend Aristocrats
Sponsored: Find a Qualified Financial Advisor Finding a qualified financial advisor doesn't have to be hard.
Investors Keep Buying These Sizzling 4 S&P Mid-Cap Dividend Aristocrats
Sponsored: Find a Qualified Financial Advisor Finding a qualified financial advisor doesn't have to be hard.
Omega Healthcare Investors: How Safe Is The 9% Yield
Healthcare REITs, like Omega Healthcare Investors, are attractive for passive income portfolios due to the long-term growth trend in the aging population. Omega Healthcare Investors provided AFFO guidance for 2024, suggesting that the dividend should be sustainable. Despite a narrower...
PGRE vs. OHI: Which Stock Is the Better Value Option?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Paramount Group (PGRE) or Omega Healthcare Investors (OHI). But which of these two stocks is more attractive to value investors?
3 Top REITs to Buy Now for High Dividend Yields
Investors looking for high dividend yields often turn to real estate investment trusts, or REITs. REITs exist virtually entirely to generate income that is then returned to shareholders via dividends.
Omega Healthcare Investors: Positioned For Long-Term Growth
A demographic change will push demand in years and decades to come. Regulations limit supply, creating a future imbalance. OHI has not been properly valuated, with excessive focus on its lack of dividend growth.
PGRE or OHI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Paramount Group (PGRE) or Omega Healthcare Investors (OHI). But which of these two stocks offers value investors a better bang for their...
My Dividend Growth Portfolio February Update
As we reach the 15th anniversary of the 2009 market lows, I am thankful to be a dividend growth investor. February brought several dividend increases to the portfolio, but there will be none in March. While the market as a...
Source: https://incomestatements.info
Category: Stock Reports